Banco Bilbao Vizcaya Argentaria, S.A. Oncolytics Biotech Inc Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$1.58 - $2.15 $47,400 - $64,500	-30,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$0.98 - $4.28 $29,400 - $128,400	30,000 New	30,000 $40,000

1.21M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.